Global Vitamin K Antagonists (VKA) Market Growth 2020-2025
According to this study, over the next five years the Vitamin K Antagonists (VKA) market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vitamin K Antagonists (VKA) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin K Antagonists (VKA) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Vitamin K Antagonists (VKA), covering the supply chain analysis, impact assessment to the Vitamin K Antagonists (VKA) market size growth rate in several scenarios, and the measures to be undertaken by Vitamin K Antagonists (VKA) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral Vitamin K Antagonists
Injection Vitamin K Antagonists
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
VTE
ACS/MI
AF
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
AstraZeneca
Bristol-Myers Squibb
Johnson & Johnson
Genentech (Roche)
Bayer
Daiichi Sankyo
Boehringer Ingelheim
Otsuka
Lilly
Pfizer
The Medicines Company
Aspen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Vitamin K Antagonists (VKA) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Vitamin K Antagonists (VKA) market by identifying its various subsegments.
Focuses on the key global Vitamin K Antagonists (VKA) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vitamin K Antagonists (VKA) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vitamin K Antagonists (VKA) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vitamin K Antagonists (VKA) Consumption 2015-2025
2.1.2 Vitamin K Antagonists (VKA) Consumption CAGR by Region
2.2 Vitamin K Antagonists (VKA) Segment by Type
2.2.1 Oral Vitamin K Antagonists
2.2.2 Injection Vitamin K Antagonists
2.3 Vitamin K Antagonists (VKA) Consumption by Type
2.3.1 Global Vitamin K Antagonists (VKA) Consumption Market Share by Type (2015-2020)
2.3.2 Global Vitamin K Antagonists (VKA) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vitamin K Antagonists (VKA) Sale Price by Type (2015-2020)
2.4 Vitamin K Antagonists (VKA) Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Others
2.5 Vitamin K Antagonists (VKA) Consumption by Application
2.5.1 Global Vitamin K Antagonists (VKA) Consumption Market Share by Type (2015-2020)
2.5.2 Global Vitamin K Antagonists (VKA) Value and Market Share by Type (2015-2020)
2.5.3 Global Vitamin K Antagonists (VKA) Sale Price by Type (2015-2020)
3 Global Vitamin K Antagonists (VKA) by Company
3.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Company
3.1.1 Global Vitamin K Antagonists (VKA) Sales by Company (2018-2020)
3.1.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Company (2018-2020)
3.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Company
3.2.1 Global Vitamin K Antagonists (VKA) Revenue by Company (2018-2020)
3.2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Company (2018-2020)
3.3 Global Vitamin K Antagonists (VKA) Sale Price by Company
3.4 Global Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vitamin K Antagonists (VKA) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vitamin K Antagonists (VKA) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Vitamin K Antagonists (VKA) by Regions
4.1 Vitamin K Antagonists (VKA) by Regions
4.2 Americas Vitamin K Antagonists (VKA) Consumption Growth
4.3 APAC Vitamin K Antagonists (VKA) Consumption Growth
4.4 Europe Vitamin K Antagonists (VKA) Consumption Growth
4.5 Middle East & Africa Vitamin K Antagonists (VKA) Consumption Growth
5 Americas
5.1 Americas Vitamin K Antagonists (VKA) Consumption by Countries
5.1.1 Americas Vitamin K Antagonists (VKA) Consumption by Countries (2015-2020)
5.1.2 Americas Vitamin K Antagonists (VKA) Value by Countries (2015-2020)
5.2 Americas Vitamin K Antagonists (VKA) Consumption by Type
5.3 Americas Vitamin K Antagonists (VKA) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Vitamin K Antagonists (VKA) Consumption by Regions
6.1.1 APAC Vitamin K Antagonists (VKA) Consumption by Regions (2015-2020)
6.1.2 APAC Vitamin K Antagonists (VKA) Value by Regions (2015-2020)
6.2 APAC Vitamin K Antagonists (VKA) Consumption by Type
6.3 APAC Vitamin K Antagonists (VKA) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Vitamin K Antagonists (VKA) by Countries
7.1.1 Europe Vitamin K Antagonists (VKA) Consumption by Countries (2015-2020)
7.1.2 Europe Vitamin K Antagonists (VKA) Value by Countries (2015-2020)
7.2 Europe Vitamin K Antagonists (VKA) Consumption by Type
7.3 Europe Vitamin K Antagonists (VKA) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Vitamin K Antagonists (VKA) by Countries
8.1.1 Middle East & Africa Vitamin K Antagonists (VKA) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vitamin K Antagonists (VKA) Value by Countries (2015-2020)
8.2 Middle East & Africa Vitamin K Antagonists (VKA) Consumption by Type
8.3 Middle East & Africa Vitamin K Antagonists (VKA) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vitamin K Antagonists (VKA) Distributors
10.3 Vitamin K Antagonists (VKA) Customer
11 Global Vitamin K Antagonists (VKA) Market Forecast
11.1 Global Vitamin K Antagonists (VKA) Consumption Forecast (2021-2025)
11.2 Global Vitamin K Antagonists (VKA) Forecast by Regions
11.2.1 Global Vitamin K Antagonists (VKA) Forecast by Regions (2021-2025)
11.2.2 Global Vitamin K Antagonists (VKA) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vitamin K Antagonists (VKA) Forecast by Type
11.8 Global Vitamin K Antagonists (VKA) Forecast by Application
12 Key Players Analysis
12.1 Sanofi
12.1.1 Company Information
12.1.2 Vitamin K Antagonists (VKA) Product Offered
12.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 AstraZeneca
12.2.1 Company Information
12.2.2 Vitamin K Antagonists (VKA) Product Offered
12.2.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 AstraZeneca Latest Developments
12.3 Bristol-Myers Squibb
12.3.1 Company Information
12.3.2 Vitamin K Antagonists (VKA) Product Offered
12.3.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bristol-Myers Squibb Latest Developments
12.4 Johnson & Johnson
12.4.1 Company Information
12.4.2 Vitamin K Antagonists (VKA) Product Offered
12.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Genentech (Roche)
12.5.1 Company Information
12.5.2 Vitamin K Antagonists (VKA) Product Offered
12.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Genentech (Roche) Latest Developments
12.6 Bayer
12.6.1 Company Information
12.6.2 Vitamin K Antagonists (VKA) Product Offered
12.6.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer Latest Developments
12.7 Daiichi Sankyo
12.7.1 Company Information
12.7.2 Vitamin K Antagonists (VKA) Product Offered
12.7.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Daiichi Sankyo Latest Developments
12.8 Boehringer Ingelheim
12.8.1 Company Information
12.8.2 Vitamin K Antagonists (VKA) Product Offered
12.8.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Boehringer Ingelheim Latest Developments
12.9 Otsuka
12.9.1 Company Information
12.9.2 Vitamin K Antagonists (VKA) Product Offered
12.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Otsuka Latest Developments
12.10 Lilly
12.10.1 Company Information
12.10.2 Vitamin K Antagonists (VKA) Product Offered
12.10.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Lilly Latest Developments
12.11 Pfizer
12.11.1 Company Information
12.11.2 Vitamin K Antagonists (VKA) Product Offered
12.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Pfizer Latest Developments
12.12 The Medicines Company
12.12.1 Company Information
12.12.2 Vitamin K Antagonists (VKA) Product Offered
12.12.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 The Medicines Company Latest Developments
12.13 Aspen
12.13.1 Company Information
12.13.2 Vitamin K Antagonists (VKA) Product Offered
12.13.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Aspen Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Vitamin K Antagonists (VKA) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral Vitamin K Antagonists
Table 5. Major Players of Injection Vitamin K Antagonists
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Vitamin K Antagonists (VKA) Consumption Market Share by Type (2015-2020)
Table 8. Global Vitamin K Antagonists (VKA) Revenue by Type (2015-2020) ($ million)
Table 9. Global Vitamin K Antagonists (VKA) Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Vitamin K Antagonists (VKA) Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Vitamin K Antagonists (VKA) Consumption Market Share by Application (2015-2020)
Table 13. Global Vitamin K Antagonists (VKA) Value by Application (2015-2020)
Table 14. Global Vitamin K Antagonists (VKA) Value Market Share by Application (2015-2020)
Table 15. Global Vitamin K Antagonists (VKA) Sale Price by Application (2015-2020)
Table 16. Global Vitamin K Antagonists (VKA) Sales by Company (2017-2019) (K MT)
Table 17. Global Vitamin K Antagonists (VKA) Sales Market Share by Company (2017-2019)
Table 18. Global Vitamin K Antagonists (VKA) Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company (2017-2019)
Table 20. Global Vitamin K Antagonists (VKA) Sale Price by Company (2017-2019)
Table 21. Global Vitamin K Antagonists (VKA) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Vitamin K Antagonists (VKA) Products Offered
Table 23. Vitamin K Antagonists (VKA) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Vitamin K Antagonists (VKA) Consumption by Regions 2015-2020 (K MT)
Table 25. Global Vitamin K Antagonists (VKA) Consumption Market Share by Regions 2015-2020
Table 26. Global Vitamin K Antagonists (VKA) Value by Regions 2015-2020 ($ Millions)
Table 27. Global Vitamin K Antagonists (VKA) Value Market Share by Regions 2015-2020
Table 28. Americas Vitamin K Antagonists (VKA) Consumption by Countries (2015-2020) (K MT)
Table 29. Americas Vitamin K Antagonists (VKA) Consumption Market Share by Countries (2015-2020)
Table 30. Americas Vitamin K Antagonists (VKA) Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Vitamin K Antagonists (VKA) Value Market Share by Countries (2015-2020)
Table 32. Americas Vitamin K Antagonists (VKA) Consumption by Type (2015-2020) (K MT)
Table 33. Americas Vitamin K Antagonists (VKA) Consumption Market Share by Type (2015-2020)
Table 34. Americas Vitamin K Antagonists (VKA) Consumption by Application (2015-2020) (K MT)
Table 35. Americas Vitamin K Antagonists (VKA) Consumption Market Share by Application (2015-2020)
Table 36. APAC Vitamin K Antagonists (VKA) Consumption by Countries (2015-2020) (K MT)
Table 37. APAC Vitamin K Antagonists (VKA) Consumption Market Share by Countries (2015-2020)
Table 38. APAC Vitamin K Antagonists (VKA) Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Vitamin K Antagonists (VKA) Value Market Share by Regions (2015-2020)
Table 40. APAC Vitamin K Antagonists (VKA) Consumption by Type (2015-2020) (K MT)
Table 41. APAC Vitamin K Antagonists (VKA) Consumption Market Share by Type (2015-2020)
Table 42. APAC Vitamin K Antagonists (VKA) Consumption by Application (2015-2020) (K MT)
Table 43. APAC Vitamin K Antagonists (VKA) Consumption Market Share by Application (2015-2020)
Table 44. Europe Vitamin K Antagonists (VKA) Consumption by Countries (2015-2020) (K MT)
Table 45. Europe Vitamin K Antagonists (VKA) Consumption Market Share by Countries (2015-2020)
Table 46. Europe Vitamin K Antagonists (VKA) Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Vitamin K Antagonists (VKA) Value Market Share by Countries (2015-2020)
Table 48. Europe Vitamin K Antagonists (VKA) Consumption by Type (2015-2020) (K MT)
Table 49. Europe Vitamin K Antagonists (VKA) Consumption Market Share by Type (2015-2020)
Table 50. Europe Vitamin K Antagonists (VKA) Consumption by Application (2015-2020) (K MT)
Table 51. Europe Vitamin K Antagonists (VKA) Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Vitamin K Antagonists (VKA) Consumption by Countries (2015-2020) (K MT)
Table 53. Middle East & Africa Vitamin K Antagonists (VKA) Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Vitamin K Antagonists (VKA) Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Vitamin K Antagonists (VKA) Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Vitamin K Antagonists (VKA) Consumption by Type (2015-2020) (K MT)
Table 57. Middle East & Africa Vitamin K Antagonists (VKA) Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Vitamin K Antagonists (VKA) Consumption by Application (2015-2020) (K MT)
Table 59. Middle East & Africa Vitamin K Antagonists (VKA) Consumption Market Share by Application (2015-2020)
Table 60. Vitamin K Antagonists (VKA) Distributors List
Table 61. Vitamin K Antagonists (VKA) Customer List
Table 62. Global Vitamin K Antagonists (VKA) Consumption Forecast by Countries (2021-2025) (K MT)
Table 63. Global Vitamin K Antagonists (VKA) Consumption Market Forecast by Regions
Table 64. Global Vitamin K Antagonists (VKA) Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Vitamin K Antagonists (VKA) Value Market Share Forecast by Regions
Table 66. Global Vitamin K Antagonists (VKA) Consumption Forecast by Type (2021-2025) (K MT)
Table 67. Global Vitamin K Antagonists (VKA) Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Vitamin K Antagonists (VKA) Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Vitamin K Antagonists (VKA) Value Market Share Forecast by Type (2021-2025)
Table 70. Global Vitamin K Antagonists (VKA) Consumption Forecast by Application (2021-2025) (K MT)
Table 71. Global Vitamin K Antagonists (VKA) Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Vitamin K Antagonists (VKA) Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Vitamin K Antagonists (VKA) Value Market Share Forecast by Application (2021-2025)
Table 74. Sanofi Product Offered
Table 75. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. Sanofi Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 79. AstraZeneca Product Offered
Table 80. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments
Table 83. AstraZeneca Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol-Myers Squibb Product Offered
Table 85. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 86. Bristol-Myers Squibb Main Business
Table 87. Bristol-Myers Squibb Latest Developments
Table 88. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Product Offered
Table 90. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 94. Genentech (Roche) Product Offered
Table 95. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 96. Genentech (Roche) Main Business
Table 97. Genentech (Roche) Latest Developments
Table 98. Genentech (Roche) Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer Product Offered
Table 100. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 101. Bayer Main Business
Table 102. Bayer Latest Developments
Table 103. Bayer Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 104. Daiichi Sankyo Product Offered
Table 105. Daiichi Sankyo Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 106. Daiichi Sankyo Main Business
Table 107. Daiichi Sankyo Latest Developments
Table 108. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 109. Boehringer Ingelheim Product Offered
Table 110. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 111. Boehringer Ingelheim Main Business
Table 112. Boehringer Ingelheim Latest Developments
Table 113. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 114. Otsuka Product Offered
Table 115. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 116. Otsuka Main Business
Table 117. Otsuka Latest Developments
Table 118. Otsuka Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 119. Lilly Product Offered
Table 120. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 121. Lilly Main Business
Table 122. Lilly Latest Developments
Table 123. Lilly Basic Information, Company Total Revenue (in $ million), Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors
Table 124. Pfizer Product Offered
Table 125. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 126. Pfizer Main Business
Table 127. Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Pfizer Latest Developments
Table 129. The Medicines Company Product Offered
Table 130. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 131. The Medicines Company Main Business
Table 132. The Medicines Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. The Medicines Company Latest Developments
Table 134. Aspen Product Offered
Table 135. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 136. Aspen Main Business
Table 137. Aspen Latest Developments
Table 138. Aspen Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Vitamin K Antagonists (VKA)
Figure 2. Vitamin K Antagonists (VKA) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Vitamin K Antagonists (VKA) Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Vitamin K Antagonists (VKA) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral Vitamin K Antagonists
Figure 7. Product Picture of Injection Vitamin K Antagonists
Figure 8. Global Vitamin K Antagonists (VKA) Consumption Market Share by Type (2015-2020)
Figure 9. Global Vitamin K Antagonists (VKA) Value Market Share by Type (2015-2020)
Figure 10. Vitamin K Antagonists (VKA) Consumed in VTE
Figure 11. Global Vitamin K Antagonists (VKA) Market: VTE (2015-2020) (K MT)
Figure 12. Global Vitamin K Antagonists (VKA) Market: VTE (2015-2020) ($ Millions)
Figure 13. Vitamin K Antagonists (VKA) Consumed in ACS/MI
Figure 14. Global Vitamin K Antagonists (VKA) Market: ACS/MI (2015-2020) (K MT)
Figure 15. Global Vitamin K Antagonists (VKA) Market: ACS/MI (2015-2020) ($ Millions)
Figure 16. Vitamin K Antagonists (VKA) Consumed in AF
Figure 17. Global Vitamin K Antagonists (VKA) Market: AF (2015-2020) (K MT)
Figure 18. Global Vitamin K Antagonists (VKA) Market: AF (2015-2020) ($ Millions)
Figure 19. Vitamin K Antagonists (VKA) Consumed in Others
Figure 20. Global Vitamin K Antagonists (VKA) Market: Others (2015-2020) (K MT)
Figure 21. Global Vitamin K Antagonists (VKA) Market: Others (2015-2020) ($ Millions)
Figure 22. Global Vitamin K Antagonists (VKA) Consumption Market Share by Application (2015-2020)
Figure 23. Global Vitamin K Antagonists (VKA) Value Market Share by Application (2015-2020)
Figure 24. Global Vitamin K Antagonists (VKA) Sales Market Share by Company in 2017
Figure 25. Global Vitamin K Antagonists (VKA) Sales Market Share by Company in 2019
Figure 26. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company in 2017
Figure 27. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company in 2019
Figure 28. Global Vitamin K Antagonists (VKA) Sale Price by Company in 2019
Figure 29. Global Vitamin K Antagonists (VKA) Consumption Market Share by Regions 2015-2020
Figure 30. Global Vitamin K Antagonists (VKA) Value Market Share by Regions 2015-2020
Figure 31. Americas Vitamin K Antagonists (VKA) Consumption 2015-2020 (K MT)
Figure 32. Americas Vitamin K Antagonists (VKA) Value 2015-2020 ($ Millions)
Figure 33. APAC Vitamin K Antagonists (VKA) Consumption 2015-2020 (K MT)
Figure 34. APAC Vitamin K Antagonists (VKA) Value 2015-2020 ($ Millions)
Figure 35. Europe Vitamin K Antagonists (VKA) Consumption 2015-2020 (K MT)
Figure 36. Europe Vitamin K Antagonists (VKA) Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Vitamin K Antagonists (VKA) Consumption 2015-2020 (K MT)
Figure 38. Middle East & Africa Vitamin K Antagonists (VKA) Value 2015-2020 ($ Millions)
Figure 39. Americas Vitamin K Antagonists (VKA) Consumption Market Share by Countries in 2019
Figure 40. Americas Vitamin K Antagonists (VKA) Value Market Share by Countries in 2019
Figure 41. Americas Vitamin K Antagonists (VKA) Consumption Market Share by Type in 2019
Figure 42. Americas Vitamin K Antagonists (VKA) Consumption Market Share by Application in 2019
Figure 43. United States Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 44. United States Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 46. Canada Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 48. Mexico Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Vitamin K Antagonists (VKA) Consumption Market Share by Countries in 2019
Figure 50. APAC Vitamin K Antagonists (VKA) Value Market Share by Regions in 2019
Figure 51. APAC Vitamin K Antagonists (VKA) Consumption Market Share by Type in 2019
Figure 52. APAC Vitamin K Antagonists (VKA) Consumption Market Share by Application in 2019
Figure 53. China Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 54. China Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 56. Japan Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 58. Korea Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 60. Southeast Asia Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 61. India Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 62. India Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 64. Australia Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Vitamin K Antagonists (VKA) Consumption Market Share by Countries in 2019
Figure 66. Europe Vitamin K Antagonists (VKA) Value Market Share by Countries in 2019
Figure 67. Europe Vitamin K Antagonists (VKA) Consumption Market Share by Type in 2019
Figure 68. Europe Vitamin K Antagonists (VKA) Consumption Market Share by Application in 2019
Figure 69. Germany Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 70. Germany Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 71. France Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 72. France Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 73. UK Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 74. UK Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 76. Italy Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 78. Russia Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Vitamin K Antagonists (VKA) Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Vitamin K Antagonists (VKA) Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Vitamin K Antagonists (VKA) Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Vitamin K Antagonists (VKA) Consumption Market Share by Application in 2019
Figure 83. Egypt Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 84. Egypt Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 86. South Africa Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 88. Israel Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 90. Turkey Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Vitamin K Antagonists (VKA) Consumption Growth 2015-2020 (K MT)
Figure 92. GCC Countries Vitamin K Antagonists (VKA) Value Growth 2015-2020 ($ Millions)
Figure 93. Global Vitamin K Antagonists (VKA) Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 94. Global Vitamin K Antagonists (VKA) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 96. Americas Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 97. APAC Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 98. APAC Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 99. Europe Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 100. Europe Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 102. Middle East & Africa Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 103. United States Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 104. United States Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 105. Canada Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 106. Canada Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 107. Mexico Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 108. Mexico Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 109. Brazil Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 110. Brazil Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 111. China Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 112. China Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 113. Japan Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 114. Japan Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 115. Korea Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 116. Korea Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 118. Southeast Asia Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 119. India Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 120. India Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 121. Australia Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 122. Australia Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 123. Germany Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 124. Germany Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 125. France Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 126. France Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 127. UK Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 128. UK Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 129. Italy Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 130. Italy Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 131. Russia Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 132. Russia Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 133. Spain Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 134. Spain Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 135. Egypt Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 136. Egypt Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 137. South Africa Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 138. South Africa Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 139. Israel Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 140. Israel Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 141. Turkey Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 142. Turkey Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Vitamin K Antagonists (VKA) Consumption 2021-2025 (K MT)
Figure 144. GCC Countries Vitamin K Antagonists (VKA) Value 2021-2025 ($ Millions)
Figure 145. Sanofi Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 146. AstraZeneca Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 147. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 148. Johnson & Johnson Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 149. Genentech (Roche) Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 150. Bayer Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 151. Daiichi Sankyo Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 152. Boehringer Ingelheim Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 153. Otsuka Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 154. Lilly Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 155. Pfizer Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 156. The Medicines Company Vitamin K Antagonists (VKA) Market Share (2018-2020)
Figure 157. Aspen Vitamin K Antagonists (VKA) Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets